Xianglin L. Du, MD, PhD

home / authors / xianglin-l-du-md-phd

Articles

May 20th 2014

Survival and Cost-Effectiveness of Hospice Care for Metastatic Melanoma Patients

Jinhai Huo, PhD, MD, MPH David R. Lairson, PhD Xianglin L. Du, MD, PhD Wenyaw Chan, PhD Thomas A. Buchholz, MD B. Ashleigh Guadagnolo, MD, MPH

Hospice care is associated with improved median survival time for the patients diagnosed with metastatic melanoma, accompanied by decreased end-of-life costs.

October 23rd 2013

Utilization of Lymph Node Dissection, Race/Ethnicity, and Breast Cancer Outcomes

Zhannat Z. Nurgalieva, MD, PhD Luisa Franzini, PhD Robert O. Morgan, PhD Sally W. Vernon, PhD Xianglin L. Du, MD, PhD

The disparities in survival among node-positive breast cancer patients of African American and Hispanic heritage are not explained by nodal surgery utilization.

May 22nd 2011

Post-treatment Surveillance in a Large Cohort of Patients With Colon Cancer

Chung-Yuan Hu, PhD George L. Delclos, MD, PhD Wenyaw Chan, PhD Xianglin L. Du, MD, PhD

Adherence to colon cancer post-treatment surveillance was low, although proportions of patients complying with office visits and colonoscopy were reasonably high.